Products

With a passion for empowering patients through revelationary
science, Aclaris seeks to secure solutions for people who suffer
from dermatological and immunological diseases.

ESKATA® (hydrogen peroxide) topical solution, 40% (w/w) was discontinued effective August 8, 2019.

RHOFADE® (oxymetazoline hydrochloride) cream, 1%, has been acquired by EPI Health.